Heparin therapy for venous thrombosis and pulmonary embolism

Blood Reviews - Tập 2 - Trang 251-258 - 1988
G.E. Raskob1, R.D. Hull1
1Departments of Medicine, and Clinical Epidemiology and Biostatistics, Chedoke-McMaster Hospitals, McMaster University, Hamilton, Ontario, Canada

Tài liệu tham khảo

Barritt, 1960, Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial, Lancet, i, 1309, 10.1016/S0140-6736(60)92299-6

Hull, 1979, Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis, New England Journal of Medicine, 301, 855, 10.1056/NEJM197910183011602

Hull, 1986, Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximalvein thrombosis, New England Journal of Medicine, 315, 1109, 10.1056/NEJM198610303151801

Salzman, 1975, Management of heparin therapy: controlled prospective trial, New England Journal of Medicine, 292, 1046, 10.1056/NEJM197505152922002

Basu, 1972, A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time, New England Journal of Medicine, 287, 324, 10.1056/NEJM197208172870703

Hull, 1982, Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis, New England Journal of Medicine, 306, 189, 10.1056/NEJM198201283060401

Hull, 1982, Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis, New England Journal of Medicine, 307, 1676, 10.1056/NEJM198212303072704

Hull, 1983, Long-term anticoagulant therapy in patients with venous thrombosis, Archives of Internal Medicine, 143, 2061, 10.1001/archinte.143.11.2061

Hyers, 1986, Antithrombotic therapy for venous thromboembolic disease, Chest, 89, 26S, 10.1378/chest.89.2_Supplement.26S

Kakkar, 1969, Natural history of postoperative deep-vein thrombosis, Lancet, ii, 230, 10.1016/S0140-6736(69)90002-6

Moser, 1981, Is embolic risk conditioned by location of deep venous thrombosis?, Annals of Internal Medicine, 94, 439, 10.7326/0003-4819-94-4-439

Huisman, 1986, Serial impedance plethysmography for suspected deep-vein thrombosis in outpatients, New England Journal of Medicine, 314, 823, 10.1056/NEJM198603273141305

Hull, 1985, Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis, Annals of Internal Medicine, 102, 21, 10.7326/0003-4819-102-1-21

Lagerstedt, 1985, Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis, Lancet, ii, 515, 10.1016/S0140-6736(85)90459-3

Rosenberg, 1977, Chemistry of the hemostatic mechanism and its relationship to the action of heparin, 36, 10

McNeely, 1985, The anticoagulant mechanism of action of heparin in contact-activated plasma; inhibition of factor X activation, Blood, 65, 1226, 10.1182/blood.V65.5.1226.1226

Ofusu, 1987, The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin, Biochemical Journal, 243, 579, 10.1042/bj2430579

Ofusu, 1985, Heparin Cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulphate, 11, 133

Eika, 1972, The platelet aggregating effect of eight commercial heparins, Scandinavian Journal of Haematology, 9, 480, 10.1111/j.1600-0609.1972.tb00973.x

Salzman, 1980, Effect of heparin and heparin fractions on platelet aggregation, Journal of Clinical Investigation, 65, 64, 10.1172/JCI109661

Heiden, 1977, Impairment by heparin of primary hemostasis and platelet 14-C-5-hydroxytryptamine release, British Journal of Haematology, 36, 427, 10.1111/j.1365-2141.1977.tb00666.x

Carter, 1982, The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits, Blood, 59, 1239, 10.1182/blood.V59.6.1239.1239

Fernandez, 1986, Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect, Thrombosis Research, 43, 491, 10.1016/0049-3848(86)90094-0

Turpie, 1986, A randomized controlled trial of a low-molecular weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery, New England Journal of Medicine, 315, 925, 10.1056/NEJM198610093151503

Bratt, 1985, A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis, Thrombosis and Haemostasis, 54, 813, 10.1055/s-0038-1660139

Holm, 1986, Subcutaneous heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin, Hemostasis, 16, 30

Carter, 1981, Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin, Thrombosis Research, 21, 169, 10.1016/0049-3848(84)90045-8

Ockelford, 1982, Discordance between the anti-Xa and the antithrombotic activity of an ultra low molecular weight heparin fraction, Thrombosis Research, 28, 401, 10.1016/0049-3848(82)90121-9

Buchanan, 1985, The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin, Blood, 65, 198, 10.1182/blood.V65.1.198.198

Buchanan, 1986, Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition, 12, 324

Bjornsson, 1982, Heparin kinetics determined by three assay methods, Clinical Pharmacology and Therapeutics, 31, 104, 10.1038/clpt.1982.16

de Swart, 1982, Kinetics of intravenously administered heparin in normal humans, Blood, 60, 1251, 10.1182/blood.V60.6.1251.1251

Hirsh, 1976, Heparin kinetics in venous thrombosis and pulmonary embolism, Circulation, 53, 691, 10.1161/01.CIR.53.4.691

Simon, 1978, Heparin pharmacokinetics: increased requirements in pulmonary embolism, British Journal of Haematology, 39, 111, 10.1111/j.1365-2141.1978.tb07133.x

Bratt, 1985, A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragment, Thrombosis and Hemostasis, 53, 208, 10.1055/s-0038-1661275

Bratt, 1986, Low molecular weight heparin (Kabi 2165, Fragmin): Pharmacokinetics after intravenous and subcutaneous administration in human volunteers, Thrombosis Research, 42, 613, 10.1016/0049-3848(86)90340-3

Matzsch, 1987, Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers, Thrombosis and Hemostasis, 57, 97, 10.1055/s-0038-1651070

Chiu, 1977, Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis, Blood, 49, 171, 10.1182/blood.V49.2.171.171

Glazier, 1976, Randomized prospective trial of continuous versus intermittent heparin therapy, JAMA, 236, 1365, 10.1001/jama.236.12.1365

Wilson, 1979, Heparin therapy: a randomized prospective study, American Heart Journal, 97, 155, 10.1016/0002-8703(79)90349-1

Mant, 1977, Hemorrhagic complications of heparin therapy, Lancet, i, 1133, 10.1016/S0140-6736(77)92388-1

Andersson, 1982, Subcutaneous administration of heparin: a randomized comparison with intravenous administration of heparin to patients with deep-vein thrombosis, Thrombosis Research, 27, 631, 10.1016/0049-3848(82)90001-9

Walker, 1987, Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep-vein thrombosis of the legs: a multicentre prospective randomized trial, British Medical Journal, 294, 1189, 10.1136/bmj.294.6581.1189

Doyle, 1987, Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep-vein thrombosis: a randomized trial, Annals of Internal Medicine, 107, 10.7326/0003-4819-107-4-441

Rooke, 1986, Heparin and the in-hospital management of deep venous thrombosis: cost considerations, 61, 198

Gallus, 1986, Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism, Lancet, ii, 1293, 10.1016/S0140-6736(86)91431-5

Whitfield, 1983, Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin, Clinical Pharmacology and Therapeutics, 34, 23, 10.1038/clpt.1983.123

Kernohan, 1966, Heparin therapy in thromboembolic disease, Lancet, i, 621, 10.1016/S0140-6736(66)90822-1

Walker, 1980, Predictors of bleeding during heparin therapy, JAMA, 244, 1209, 10.1001/jama.244.11.1209

Bell, 1980, Heparin-associated thrombocytopenia: a comparison of three heparin preparations, New England Journal of Medicine, 303, 902, 10.1056/NEJM198010163031602

Green, 1984, Thrombocytopenia in a prospective randomized double-blind trial of bovine and porcine heparin, American Journal of the Medical Sciences, 288, 60, 10.1097/00000441-198409000-00003

Cimo, 1979, Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses, American Journal of Haematology, 6, 125, 10.1002/ajh.2830060204

Babcock, 1976, Heparin-induced immune thrombocytopenia, New England Journal of Medicine, 295, 237, 10.1056/NEJM197607292950501

Cines, 1980, Heparin-associated thrombocytopenia, New England Journal of Medicine, 303, 788, 10.1056/NEJM198010023031404

Sackler, 1973, Heparin-induced osteoporosis, British Journal of Radiology, 46, 548, 10.1259/0007-1285-46-547-548

Squires, 1979, Heparin-induced spinal fractures, JAMA, 241, 2417, 10.1001/jama.241.22.2417

Wise, 1980, Heparin-induced osteopenia in pregnancy, British Medical Journal, 281, 110, 10.1136/bmj.281.6233.110

Thông tin
Thông tin xuất bản

Blood Reviews

Tập 2

251-258

Thông tin tác giả